Assignee
ELEVATION ONCOLOGY INC
US·0 granted patents·3 pending applications·0 citations·filing 2021–2024
Top patents by PatentIndex Score
3 records- 0190US2024360243A1Antibodies against the ectodomain of erbb3 and uses thereofELEVATION ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 0279US2022204642A1Antibodies against the ectodomain of erbb3 and uses thereofELEVATION ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 0352US2022288204A1Dosage and administration of anti-erbb3 (her3) monoclonal antibodies to treat tumors associated with neuregulin 1 (nrg1) gene fusionsELEVATION ONCOLOGY INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ELEVATION ONCOLOGY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →